Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
August 28, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-030698.pdf 0001628280-23-030698.rtf 0001628280-23-030698.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 8, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-037557.pdf 0001628280-23-037557.rtf 0001628280-23-037557.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 15, 2020	PRER14A	Proxy soliciting materials. Revised preliminary material	0001193125-20-107370.pdf 0001193125-20-107370.rtf 0001193125-20-107370.xls View HTML
October 25, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-307890.pdf 0001193125-18-307890.rtf 0001193125-18-307890.xls View HTML
October 29, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-309873.pdf 0001193125-18-309873.rtf 0001193125-18-309873.xls View HTML
April 13, 2015	S-3/A	Pre-effective amendment to an S-3 filing	0001193125-15-126906.pdf 0001193125-15-126906.rtf 0001193125-15-126906.xls View HTML
March 1, 2022	POS AM	Post-effective amendment to an S-Type filing	0001193125-22-061620.pdf 0001193125-22-061620.rtf 0001193125-22-061620.xls View HTML
March 1, 2022	POSASR	POSASR	0001193125-22-061326.pdf 0001193125-22-061326.rtf 0001193125-22-061326.xls View HTML
April 30, 2015	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-15-159076.pdf 0001193125-15-159076.rtf 0001193125-15-159076.xls View HTML
April 29, 2016	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-16-569284.pdf 0001193125-16-569284.rtf 0001193125-16-569284.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax